Court Ruling Could Affect Genetic Patenting
A federal court ruling striking down patents on two cancer-causing genes has the potential to shake up the world of genetic patenting. Last year, the American Civil Liberties Union, together with 18 individual plaintiffs, brought a suit against Myriad Genetics, which holds the licenses to the patents on the BRCA1 and BRCA2 genes, which can…